Inventor profile of:

DANIEL COHEN

City:

LE VESINET

Country:

France

Published Applications:

34

Last publication date:

2019-10-03

Top Assignees for applications by DANIEL COHEN

The entities that hold a legal rights for patent applications filed by inventor COHEN DANIEL:

Recent patent applications by COHEN DANIEL

DANIEL COHEN from LE VESINET, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-10-03
US20190298698A1
Human necessities

Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function

#2 | 2019-09-26
US20190290578A1
Human necessities

Stable oral solutions for combined API

#3 | 2016-09-15
US20160263104A1
Human necessities

Compositions for treating CMT and related disorders

#4 | 2016-05-19
US20160136136A1
Human necessities

Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function

#5 | 2016-04-28
US20160113867A1
Human necessities

Stable oral solutions for combined API

#6 | 2015-06-11
US20150157626A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING CMT AND RELATED DISORDERS

#7 | 2014-12-25
US20140378440A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#8 | 2014-12-18
US20140371277A1
Human necessities

Compositions for treating amyotrophic lateral sclerosis

#9 | 2014-12-18
US20140371229A1
Human necessities

Therapeutic approaches for treating parkinson's disease

#10 | 2014-12-04
US20140357648A1
Human necessities

Therapeutic approaches for treating Alzheimer's disease

#11 | 2014-08-21
US20140235599A1
Human necessities

Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders

#12 | 2014-06-26
US20140178463A1
Human necessities

Compositions for treating CMT and related disorders

#13 | 2014-03-20
US20140080873A1
Human necessities

Treatment of cerebral ischemia

#14 | 2014-02-06
US20140038927A1
Human necessities

Compositions for treating neurological disorders

#15 | 2013-08-22
US20130217036A1
Physics

Diagnostic tools for charcot-marie-tooth disease

#16 | 2013-04-11
US20130090307A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#17 | 2013-04-04
US20130085122A1
Human necessities

Baclofen and acamprosate based therapy of neurological disorders

#18 | 2012-11-08
US20120283114A1
Chemistry; metallurgy

Method for detecting a panel of biomarkers

#19 | 2012-10-25
US20120270836A1
Human necessities

Therapeutic approaches for treating alzheimer'S disease

#20 | 2012-05-03
US20120108528A1
Human necessities

Therapeutic approaches for treating neuroinflammatory conditions

#21 | 2012-04-12
US20120088744A1
Human necessities

COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS

#22 | 2012-03-22
US20120071483A1
Human necessities

Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response

#23 | 2012-03-08
US20120058992A1
Human necessities

Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of angiogenesis

#24 | 2012-02-16
US20120040940A1
Human necessities

Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders

#25 | 2011-11-03
US20110269764A1
Human necessities

THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION

#26 | 2010-12-09
US20100310641A1
Human necessities

Therapeutic approaches for treating CMT and related disorders

#27 | 2010-09-16
US20100234236A1
Physics

Disease treatment by predicting drug association

#28 | 2010-01-28
US20100022846A1
Physics

Method for Health Monitoring

#29 | 2009-05-28
US20090136450A1
Human necessities

THERAPY FOR NEUROLOGICAL DISEASES

#30 | 2008-10-16
US20080254451A1
Chemistry; metallurgy

Compositions and Methods for Treating Schizophrenia and Related Disorders

#31 | 2008-07-31
US20080184381A1
Chemistry; metallurgy

SCHIZOPHRENIA-RELATED VOLTAGE-GATED ION CHANNEL GENE AND PROTEIN

#32 | 2008-07-31
US20080182268A1
Chemistry; metallurgy

SCHIZOPHRENIA ASSOCIATED GENES, PROTEINS AND BIALLELIC MARKERS

#33 | 2007-10-25
US20070249518A1
Chemistry; metallurgy

Compositions and Methods for Treating Mental Disorders

#34 | 2006-12-07
US20060275758A1
Chemistry; metallurgy

Use of pp2a phosphatase modulators in the treatment of mental disorders

InventorID:

177998 ⎘